SubsidieMeestersTUCUVI Voice and Artificial Intelligence to reduce the impact of chronic diseases
TUCUVI is an AI-driven virtual medical assistant that conducts personalized phone consultations to monitor patient symptoms and enhance preventive care through intelligent dialogue and clinical protocols.
Projectdetails
Introduction
TUCUVI is a virtual medical assistant that converses with large volumes of patients through phone calls in an intelligent and personalized dialogue. It provides and collects medical information, monitors the evolution of symptoms, and intelligently identifies alerts that allow medical teams to plan and act preventively based on clinical protocols and clinical evidence.
Features
Dialog Manager and Database
TUCUVI provides a groundbreaking Dialog manager and a unique prospective Medical Phone Calls database.
Language-Agnostic Platform
As a language-agnostic platform, it uses breakthrough AI models based on:
- NLP (Natural Language Processing)
- Transfer Learning
- Machine Learning
This is complemented by a solid Medical Knowledge base.
Management of Medical Calls
It can manage massive amounts of medical phone calls to monitor any patient, on any pathology, in a non-supervised way to reduce chronic disease impact.
Performance
TUCUVI’s AI has currently conversed empathetically with patients for over 50,000 hours, in 3 languages, about 12 medical protocols.
Certification
It is the only voice-based conversational software CE marked as a medical device.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.500.000 |
| Totale projectbegroting | € 3.634.848 |
Tijdlijn
| Startdatum | 1-2-2023 |
| Einddatum | 31-7-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- TUCUVI CARE SOCIEDAD LIMITADApenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming systemToopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability. | EIC Accelerator | € 2.396.457 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes. | EIC Accelerator | € 2.306.500 | 2024 | Details |
Miniaturised Respiratory Assist to treat acute lung failure patients using a breakthrough hyperbaric technologyHBOX Therapies aims to commercialize MiRA, a novel hyperoxygenation therapy for acute lung failure, enhancing patient outcomes while reducing reliance on invasive ventilation. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Toopi Regen: Unleash the power of urine to finally scale a real closed loop and regenerative farming system
Toopi Organics aims to revolutionize agriculture by up-cycling human urine into sustainable biostimulants, reducing reliance on mineral fertilizers while enhancing soil health and farmer profitability.
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents"""
NIMBLE Diagnostics is developing a microwave-based device for non-invasive stent monitoring, aiming to shift from reactive to proactive care and improve patient outcomes.
Miniaturised Respiratory Assist to treat acute lung failure patients using a breakthrough hyperbaric technology
HBOX Therapies aims to commercialize MiRA, a novel hyperoxygenation therapy for acute lung failure, enhancing patient outcomes while reducing reliance on invasive ventilation.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Closed-loop Individualized image-guided Transcranial Ultrasonic StimulationThe project aims to develop a neuronavigated transcranial ultrasound stimulation (TUS) system for precise, non-invasive modulation of deep brain structures to treat neurological and psychiatric disorders. | EIC Pathfinder | € 3.799.402 | 2022 | Details |
AI to predict Cancer metastasis using Ultra-Echo-Sono imagingAI CUrES aims to enhance early diagnosis and pre-emptive therapies for cancer metastasis by utilizing nanosized-contrast agents and AI-driven bioimaging of extracellular vesicles from colorectal tumors. | ERC POC | € 150.000 | 2022 | Details |
YOUR HEALFIE VOICEHet project ontwikkelt een AI-systeem voor stemanalyse om vocale biomarkers te identificeren, met als doel diagnoses te stellen voor onverklaarbare klachten en vroegtijdige signalering van gezondheidsproblemen. | MIT Haalbaarheid | € 20.000 | 2023 | Details |
CIV-AssistHet project ontwikkelt een AI-gestuurde telefonische assistent om fysiopraktijken te ontlasten door het automatiseren van telefoongesprekken, wat tijd en kosten bespaart en de zorgkwaliteit verbetert. | MIT Haalbaarheid | € 20.000 | 2022 | Details |
Closed-loop Individualized image-guided Transcranial Ultrasonic Stimulation
The project aims to develop a neuronavigated transcranial ultrasound stimulation (TUS) system for precise, non-invasive modulation of deep brain structures to treat neurological and psychiatric disorders.
AI to predict Cancer metastasis using Ultra-Echo-Sono imaging
AI CUrES aims to enhance early diagnosis and pre-emptive therapies for cancer metastasis by utilizing nanosized-contrast agents and AI-driven bioimaging of extracellular vesicles from colorectal tumors.
YOUR HEALFIE VOICE
Het project ontwikkelt een AI-systeem voor stemanalyse om vocale biomarkers te identificeren, met als doel diagnoses te stellen voor onverklaarbare klachten en vroegtijdige signalering van gezondheidsproblemen.
CIV-Assist
Het project ontwikkelt een AI-gestuurde telefonische assistent om fysiopraktijken te ontlasten door het automatiseren van telefoongesprekken, wat tijd en kosten bespaart en de zorgkwaliteit verbetert.